Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 06:01 am Sale | 2024-09-03 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | St George Street Capital | 0 0.000% | -2 (Position Closed) | Filing History |
| 2024-10-18 4:15 pm Sale | 2024-10-11 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 1 2.000% | -2 (-66.67%) | Filing History |
| 2024-10-11 06:01 am Purchase | 2024-08-07 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | ASTRAZENECA PLC AZN | 3 9.900% | 3 (New Position) | Filing History |
| 2024-10-07 7:36 pm Sale | 2024-10-04 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 3 8.300% | -2 (-40.00%) | Filing History |
| 2024-09-19 4:59 pm Sale | 2024-03-26 | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Corvus Capital Ltd. | 10 31.560% | -5 (-33.33%) | Filing History |
| 2024-08-13 4:29 pm Purchase | 2024-08-06 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 5 14.800% | 3 (+150.00%) | Filing History |
| 2024-02-12 12:51 pm Unchanged | 2023-12-31 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Polar Asset Management Partners Inc. | 0 1.300% | 0 (Unchanged) | Filing History |
| 2024-02-08 1:15 pm Unchanged | 2023-12-31 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Saba Capital Management L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-02 4:28 pm Unchanged | 2023-12-31 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Hudson Bay Capital Management LP | 0 0.100% | 0 (Unchanged) | Filing History |
| 2023-10-02 4:30 pm Purchase | 2023-09-22 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | Nirland Limited | 2 8.800% | 2 (New Position) | Filing History |
| 2023-09-29 4:30 pm Purchase | 2023-09-22 | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Corvus Capital Ltd. | 15 62.960% | 15 (New Position) | Filing History |
| 2023-09-29 4:30 pm Purchase | 2023-09-22 | 13D | CONDUIT PHARMACEUTICALS INC CO CDT | Murphy Canyon Acquisition Sponsor LLC | 2 6.500% | 1 (+100.00%) | Filing History |
| 2023-09-29 4:30 pm Purchase | 2023-09-22 | 13G | CONDUIT PHARMACEUTICALS INC CO CDT | St George Street Capital | 2 6.600% | 2 (New Position) | Filing History |
| 2023-02-16 5:28 pm Purchase | 2022-02-13 | 13D | MURPHY CANYON ACQUISITION CORP MURF | Shaolin Capital Management LLC | 609,750 20.730% | 609,750 (New Position) | Filing History |
| 2023-02-14 12:08 pm Sale | 2022-12-31 | 13G | MURPHY CANYON ACQUISITION CORP MURF | MMCAP International Inc. SPC | 350,000 2.500% | -350,000 (-50.00%) | Filing History |
| 2023-02-10 2:54 pm Purchase | 2022-12-31 | 13G | MURPHY CANYON ACQUISITION CORP MURF | Hudson Bay Capital Management LP | 934,112 6.680% | 934,112 (New Position) | Filing History |
| 2023-02-10 1:46 pm Purchase | 2022-12-31 | 13G | MURPHY CANYON ACQUISITION CORP MURF | Polar Asset Management Partners Inc. | 700,000 5.010% | 700,000 (New Position) | Filing History |
| 2023-02-07 7:31 pm Unchanged | 2022-12-31 | 13G | CSLM ACQUISITION CORP. UNIT CSLUF | Space Summit Capital LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-01-30 5:00 pm Unchanged | 2022-02-02 | 13D | MURPHY CANYON ACQUISITION CORP MURF | Murphy Canyon Acquisition Sponsor LLC | 4,060,250 23.490% | 0 (Unchanged) | Filing History |
| 2022-02-14 4:30 pm Purchase | 2022-02-02 | 13D | MURPHY CANYON ACQUISITION CORP MURF | Murphy Canyon Acquisition Sponsor LLC | 4,060,250 23.490% | 4,060,250 (New Position) | Filing History |